Posted On:
December 13, 2009
Drug Blog Round-Up
Here’s what we’re looking at, this week:
- AstraZeneca sets up a website devoted to its social networking efforts: Twitter, Facebook, YouTube and blogging
- Judge Keenan denies Merck’s motion to dismiss 24 Fosamax lawsuits because a jury may be able to conclude that the drug can cause jaw damage in under 3 years of use
- Increasing use of antipsychotics by pediatric patients
- The Pharma Marketing Blog reports on Big Pharma’s direct to consumer (DTC) advertising trends
- Informative post by Tom Lamb and the Drug Injury Watch on detecting adverse drug reactions and pulmonary embolism
Happy Monday!
